Publications
- Expression Levels of Enzymes Metabolizing an Anticancer Drug Ellipticine Determined by Electromigration Assays Influence its Cytotoxicity to Cancer Cells - A Comparative Study2014 | Faculty of Science, Second Faculty of Medicine
- Electrochemical Determination of Enzymes Metabolizing Ellipticine in Thyroid Cancer Cells - a Tool to Explain the Mechanism of Ellipticine Toxicity to these Cells2013 | Faculty of Science, Second Faculty of Medicine
- Ellipticine oxidation and DNA adduct formation in human hepatocytes is catalyzed by human cytochromes P450 and enhanced by cytochrome b52012 | Faculty of Science
- Ellipticine cytotoxicity to cancer cell lines - a comparative study2011 | Faculty of Science, First Faculty of Medicine, Faculty of Physical Education and Sport
- Anticancer agent ellipticine combined with histone deacetylase inhibitors, valproic acid and trichostatin A, is an effective DNA damage strategy in human neuroblastoma2011 | Faculty of Science, First Faculty of Medicine, Faculty of Physical Education and Sport
- The mechanism of cytotoxicity and DNA adduct formation by the anticancer drug ellipticine in human neuroblastoma cells2009 | Faculty of Science, First Faculty of Medicine, Faculty of Physical Education and Sport
- Mammalian peroxidases activate anticancer drug ellipticine to intermediates forming deoxyguanosine adducts in DNA identical to those found in vivo and generated from 12-hydroxyellipticine and 13-hydroxyellipticine2007 | Faculty of Science, Second Faculty of Medicine, Central Library of Charles University
- DNA adduct formation by the anticancer drug ellipticine in human leukemia HL-60 and CCRF-CEM cells2007 | Faculty of Science, Second Faculty of Medicine
- The effect of pH on peroxidase-mediated oxidation of and DNA adduct formation by ellipticine2006 | Faculty of Science
- Oxidation of an antitumor drug ellipticine by peroxidases2005 | Faculty of Science
Loading network view...